Cargando…
Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change
INTRODUCTION: Artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) are the first line therapy of uncomplicated malaria in Burkina Faso. We assessed the treatment efficacy, tolerability of these drugs 11 years following its adoption as first line treatment. METHODS: In this opened randomize...
Autores principales: | Zongo, Issaka, Compaoré, Yves Daniel, Nikiéma, Frédéric, Zongo, Moussa, Barry, Nouhoun, Somé, Fabrice Anyirékun, Kaboré, Naomie, Ouédraogo, Jean Bosco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250195/ https://www.ncbi.nlm.nih.gov/pubmed/32537072 http://dx.doi.org/10.11604/pamj.2020.35.68.20849 |
Ejemplares similares
-
Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso
por: Compaoré, Yves Daniel, et al.
Publicado: (2021) -
P084: Analysis of therapeutic efficacies of amodiaquine-arstesunate and artemether-lumefantrine for treatment of uncomplicated falciparum malaria in Burkina Faso five years after their implementation
por: Nikiema, FW, et al.
Publicado: (2013) -
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016) -
Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2016) -
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso
por: Beshir, Khalid B., et al.
Publicado: (2021)